Family experiences caring for children with spinal muscular atrophy
Part of Brain & nervous system, Digestive system, Ear, nose & throat, Genetic & congenital clinical trials.
This research study asks parents and caregivers about their lived experiences caring for children with SMA type 1 (a rare genetic condition affecting muscle strength), particularly around feeding and communication. Your honest feedback helps doctors and nurses better understand and support families like yours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a parent, guardian, grandparent, or relative with full parental responsibility for a child diagnosed with SMA type 1
- Your child has received at least one disease-modifying therapy (a medicine designed to slow or improve the condition)
- You are able to speak and interview in English without needing an interpreter
- You are not a foster carer or corporate parent (i.e., your child is not in state care or foster care)
- You are willing to participate in an interview about your family's feeding and communication experiences
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how speech, communication, and swallowing (“bulbar function”) develop in babies and children with SMA type 1. It aims to better understand what to expect over time for children who start approved SMA treatments early.
This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.
This study tests a virtual reality rehabilitation program for young people with SMA (spinal muscular atrophy, a genetic muscle-weakening condition). Researchers want to understand if VR-based exercises can help improve function and quality of life.
This study looks at how spinal muscular atrophy (SMA)—a condition that weakens muscles—affects the adrenal glands (which make hormones) and bones in children and young people. Researchers will use existing health information to understand these complications better and help improve care.
This study is looking for children and teens with spinal muscular atrophy (SMA) who are already on a treatment like Spinraza, Evrysdi, or Zolgensma. The goal is to understand different forms of SMA and how the treatment affects them over time.
This is a long-term observation study that follows people affected by spinal muscular atrophy (SMA), people who carry the SMA gene but have no symptoms, and families of people with SMA. It helps researchers better understand SMA and related genetic status, which can support future treatment planning.
Hear when a new Spinal Muscular Atrophy 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.